Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

FDA grants fast track designation to Toca-511 & Toca-FC for recurrent glioma

July 10, 2015

Prima Biomed receives positive scientific advice from the EMA for IMP-321

July 8, 2015

Innate Pharma receives initial payment from AstraZeneca under IPH-2201 agreement

July 8, 2015

Janssen opens daratumumab expanded access program in U.S.

July 7, 2015

Five Prime Therapeutics begins phase I/II trial of FPA-008

July 7, 2015

FDA accepts IND for MAGE-A10 T for NSCLC

July 6, 2015

CEA-targeted cytokine targets tumoral cells and shows immmune activity in tumor site

July 6, 2015

Phase I study shows promising results for GS-5745 in patients with advanced solid tumors

July 6, 2015

Yervoy receives approval for unresectable malignant melanoma in Japan

July 3, 2015

Scientists disclose phase I results for PepCan

July 2, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026